Novo-Nordisk Revenue Quarterly:
3.435B for March 31, 2013Novo-Nordisk Historical Revenue Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 3.435B |
| Dec. 31, 2012 | 3.723B |
| Sept. 30, 2012 | 3.438B |
| June 30, 2012 | 3.260B |
| March 31, 2012 | 3.178B |
| Dec. 31, 2011 | 3.158B |
| Sept. 30, 2011 | 3.007B |
| June 30, 2011 | 3.081B |
| March 31, 2011 | |
| Dec. 31, 2010 | 2.861B |
| Sept. 30, 2010 | 2.838B |
| June 30, 2010 | 2.519B |
| March 31, 2010 | 2.465B |
| Dec. 31, 2009 | 2.517B |
| Sept. 30, 2009 | 2.454B |
| June 30, 2009 | 2.460B |
| March 31, 2009 | 2.213B |
| Dec. 31, 2008 | 2.409B |
| Sept. 30, 2008 | 2.170B |
| June 30, 2008 | 2.354B |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More
NVO Revenue Quarterly Benchmarks
| Companies | |
|---|---|
| Eli Lilly and Company | 5.602B |
| Emisphere Technologies | 0.00 |
| Arena Pharmaceuticals | 2.373M |
NVO Revenue Quarterly Rankings
| Overall |
95th percentile 337 of 8002 |
| Sector |
95th percentile 29 of 650 in Healthcare |
| Industry |
99th percentile 2 of 237 in Biotechnology |
NVO Revenue Quarterly Range, Past 5 Years
| Minimum | 2.170B | Sep 2008 |
| Maximum | 3.723B | Dec 2012 |
| Average | 2.818B |